288 related articles for article (PubMed ID: 19033381)
1. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
[TBL] [Abstract][Full Text] [Related]
2. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
3. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
[TBL] [Abstract][Full Text] [Related]
4. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
Fasci D; Anania VG; Lill JR; Salvesen GS
Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
[TBL] [Abstract][Full Text] [Related]
5. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
Wang L; Wansleeben C; Zhao S; Miao P; Paschen W; Yang W
EMBO Rep; 2014 Aug; 15(8):878-85. PubMed ID: 24891386
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
7. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.
Bailey D; O'Hare P
Biochem J; 2005 Dec; 392(Pt 2):271-81. PubMed ID: 16117725
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
10. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
[TBL] [Abstract][Full Text] [Related]
11. SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.
Han Y; Huang C; Sun X; Xiang B; Wang M; Yeh ET; Chen Y; Li H; Shi G; Cang H; Sun Y; Wang J; Wang W; Gao F; Yi J
J Biol Chem; 2010 Apr; 285(17):12906-15. PubMed ID: 20181954
[TBL] [Abstract][Full Text] [Related]
12. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
13. SUSP1 antagonizes formation of highly SUMO2/3-conjugated species.
Mukhopadhyay D; Ayaydin F; Kolli N; Tan SH; Anan T; Kametaka A; Azuma Y; Wilkinson KD; Dasso M
J Cell Biol; 2006 Sep; 174(7):939-49. PubMed ID: 17000875
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
16. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
[TBL] [Abstract][Full Text] [Related]
17. Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments.
Scherer M; Reuter N; Wagenknecht N; Otto V; Sticht H; Stamminger T
J Gen Virol; 2013 Jun; 94(Pt 6):1373-1384. PubMed ID: 23407422
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
19. SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.
Sang J; Yang K; Sun Y; Han Y; Cang H; Chen Y; Shi G; Wang K; Zhou J; Wang X; Yi J
Biochem J; 2011 Apr; 435(2):489-98. PubMed ID: 21291420
[TBL] [Abstract][Full Text] [Related]
20. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
